支气管哮喘(简称哮喘)是多种细胞和细胞组分参与的气道慢性炎性反应性疾病。其发病的主要危险因素是个体变应体质和环境因素。最新的研究显示,世界上已有近3亿的哮喘患者,而且其发病率还在呈不断发展的趋势。目前,治疗哮喘的药物种类颇多,本文对药物治疗的进展进行总结。 Bronchial asthma (referred to as asthma) is a chronic airway inflammatory inflammatory disease involving a variety of cells and cellular components. The incidence of the main risk factors are individual allergies and environmental factors. The latest research shows that there are nearly 300 million asthma patients in the world, and its incidence is still showing a trend of continuous development. Currently, there are quite a number of different types of drugs used to treat asthma. This article summarizes the progress of drug treatment.